Article Text
Abstract
As a result of the increase in genetic testing and the fear of discrimination by insurance companies, employers, and society as a result of genetic testing, the disciplines of ethics, public health, and genetics have converged. Whether relatives of someone with a positive predictive genetic test should be notified of the results and risks is a matter urgently in need of debate. Such a debate must encompass the moral and ethical obligations of the diagnosing physician and the patient. The decision to inform or not will vary depending on what moral theory is used. Utilising the utilitarian and libertarian theories produces different outcomes. The principles of justice and non-maleficence will also play an important role in the decision.
- ADPKD, autosomal dominant polycystic kidney disease
- HIPAA, Health Insurance Portability and Accountability Act
- NTD, neural tube defects
- genetics
- public health
- primary care
Statistics from Altmetric.com
Footnotes
Read the full text or download the PDF:
Other content recommended for you
- The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation
- ‘A sword of Damocles’: patient and caregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominant polycystic kidney disease: a focus group study
- Cardiovascular genetics: the role of genetic testing in diagnosis and management of patients with hypertrophic cardiomyopathy
- Primary prevention of neurological illness early in life
- A step forward, but still inadequate: Australian health professionals’ views on the genetics and life insurance moratorium
- Medicolegal and insurance issues regarding BRCA1 and BRCA2 gene tests in high income countries
- Co-design of patient information leaflets for germline predisposition to cancer: recommendations for clinical practice from the UK Cancer Genetics Group (UKCGG), Cancer Research UK (CRUK) funded CanGene-CanVar Programme and the Association of Genetic Nurse Counsellors (AGNC)
- The complexities of predictive genetic testing
- Autosomal dominant polycystic kidney disease
- Genetic testing in motor neuron disease and frontotemporal dementia: a 5-year multicentre evaluation